leisure time -WSS

leisure time

author：focus 2025-09-27 12:54:58 - browse：4156

A black and white cutout photo of Feng Zhang on the left of a black and white cutout photo of Alex Aravanis. Both photos are placed on top of yellow geometric shapes and a gradient dark blue background. — Researcher Feng Zhang, left, and Alex Aravanis, the CEO of Moonwalk. Illustration: Christine Kao/STAT; Photo: Katherine Taylor for STAT and Business Wire

A new startup co-founded by CRISPR innovator Feng Zhang, a former executive at Grail and Illumina, and others has raised $57 million to develop a defanged form of gene editing that doesn’t cut the DNA strand.

Moonwalk Therapeutics launched Thursday with funding from Alpha Wave Ventures, ARCH Venture Partners, Future Ventures, Khosla Ventures, GV, and YK Bioventures. It plans to use that money to develop treatments for a variety of diseases, including chronic and aging-related conditions, using what’s called epigenetic editing.

Most of the gene editing technologies being used today slice or nick the DNA strand and make permanent changes to the biological building blocks of genes. Moonwalk, however, plans to alter the activity of genes by focusing on chemical changes. The company is targeting the surrounding chemicals that influence how genes act. This can be done through chemical processes methylation, which turns genes on, or demethylation, which turns genes off.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Bernie brings in new pharma CEOs to talk drug prices

WSS

Lawsuit challenges CMS nursing home minimum staffing rule

Surgery pushed Ben Carson to fame

Congress: Prevent baby formula shortages by passing a new bill

The Bio Revolution is changing business and society

Pharma’s losing bet in New Jersey

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

hotspot

leisure time

knowledge

Guidelines to prevent youth baseball injuries need more muscle

Bird flu makes raw milk dangerous to consume, mouse study finds

BioMarin wins approval for gene therapy to treat hemophilia A

Achieving telehealth equity for people with hearing loss

Peter Hotez and the public health issue of online harassment

Unique patient identifier: Experts argue the benefits, pitfalls

The cancer drug shortage isn’t new — and neither are the solutions

Pharma’s losing bet in New Jersey

United colonoscopy coverage change 'may cost lives,' doctors say

AI gets buy

knowledge

Congress: Prevent baby formula shortages by passing a new bill

Bird flu makes raw milk dangerous to consume, mouse study finds

340B reform proposal comes out of Senate working group

Protect nursing home residents from future pandemics

Medicare Advantage plans can’t deny care with AI, CMS warns

Congress: Prevent baby formula shortages by passing a new bill

hotspot

explore

Wikipedia

hotspot